Aspirin unneeded with anticoagulation/clopidogrel after MI, PCI in AF; vegetarian diet linked to longer life; FDA: Rosiglitazone does not up CV risk; New obesity drug, lorcaserin
Aspirin unneeded with anticoagulation/clopidogrel after MI, PCI in AF; vegetarian diet linked to longer life; FDA: Rosiglitazone does not up CV risk; New obesity drug, lorcaserin
Source: Blogs@theHeart.org - Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: blogs
More News: Aspirin | Avandia | Blogging | Cardiology | Clopidogrel | Eating Disorders & Weight Management | Heart | Nutrition | Obesity | Plavix | Vegetarian